No black box warning on record for Norgestimate And Ethinyl Estradiol

As of the latest FDA labeling reviewed, Norgestimate And Ethinyl Estradiol (NORGESTIMATE AND ETHINYL ESTRADIOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Norgestimate And Ethinyl Estradiol medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Thromboembolic Disorders and Other Vascular Problems : Stop Sprintec if a thrombotic event occurs. Stop at least 4 weeks before and through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding. ( 5.1 ) Liver disease : Discontinue Sprintec if jaundice occurs. ( 5.2 ) High blood pressure : If used in women with well-

No black box warning on record for Norgestimate And Ethinyl Estradiol

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Thromboembolic Disorders and Other Vascular Problems : Stop Sprintec if a thrombotic event occurs. Stop at least 4 weeks before and through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding. ( 5.1 ) Liver disease : Discontinue Sprintec if jaundice occurs. ( 5.2 ) High blood pressure : If used in women with well-

Norgestimate And Ethinyl Estradiol Black Box Warning

No black box warning on record for Norgestimate And Ethinyl Estradiol

Other warnings & precautions

Norgestimate And Ethinyl Estradiol Black Box Warning

No black box warning on record for Norgestimate And Ethinyl Estradiol

Other warnings & precautions